{"id":401249,"date":"2020-12-16T15:03:06","date_gmt":"2020-12-16T20:03:06","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=401249"},"modified":"2020-12-16T15:03:06","modified_gmt":"2020-12-16T20:03:06","slug":"meridian-bioscience-receives-nih-award-for-supporting-rapid-development-of-revogene-molecular-test-for-sars-cov-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/meridian-bioscience-receives-nih-award-for-supporting-rapid-development-of-revogene-molecular-test-for-sars-cov-2\/","title":{"rendered":"Meridian Bioscience receives NIH Award for supporting rapid development of Revogene\u00ae molecular test for SARS-CoV-2"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">CINCINNATI, Dec.  16, 2020  (GLOBE NEWSWIRE) &#8212; Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced that it has been awarded funding in the amount of approximately $1M by the National Institute of Health (NIH) Rapid Acceleration of Diagnostics (RADx<sup>SM<\/sup>) initiative, to expedite the launch of the company\u2019s SARS-CoV-2 molecular diagnostic test on the Revogene<sup>\u00ae<\/sup> platform. On December 7, the application for Emergency Use Authorization (EUA) for the Revogene<sup>\u00ae<\/sup> SARS-CoV-2 assay was submitted to the U.S. Food and Drug Administration (FDA).<\/p>\n<p align=\"justify\">NIH funds were critical to support the development of a new assay consumable for the Revogene<sup>\u00ae<\/sup> platform enabling the detection of RNA targets, such as SARS-CoV-2 genomic RNA, directly from viral transport media without pre-dilution in the sample workflow. To achieve this goal, a new assay formulation was needed to not only optimize the microfluidic properties of our PIE assay device, but to also enable new enzymology and internal processing controls to ensure robust clinical results. The RADx<sup>SM<\/sup> initiative further provided access to several experienced consultants and through the Center for Advancing Point of Care Technology (CAPCaT) program, gave us the ability to perform external clinical testing on our SARS-CoV-2 assay.<\/p>\n<p align=\"justify\">\u201cThe NIH contribution to our SARS-CoV-2 assay was instrumental in our goal achievement, providing a kick-start to meet our product development milestones and helping us create a new generation PIE device for the detection of respiratory viral targets directly from unprocessed specimens,\u201d said Dr. Lawrence Mertz, Senior Vice President, Diagnostics Research &amp; Clinical Development. \u201cWe are now using this innovation to expand our respiratory viral menu on the Revogene<sup>\u00ae<\/sup> platform.\u201d<\/p>\n<p align=\"justify\">The RADx<sup>SM<\/sup> initiative was launched by NIH to speed innovation in the development, commercialization, and implementation of technologies for COVID-19 testing. Meridian Bioscience is one of forty-seven projects that made the cut and moved to Phase 1, a rigorous four to six-week period of initial technology validation.\u00a0<\/p>\n<p align=\"justify\">This project has been funded in part by the NIH Rapid Acceleration of Diagnostics (RADx<sup>SM<\/sup>) initiative with federal funds from the National Institute of Biomedical Imaging and Bioengineering, National Heart, Lung and Blood Institute, National Institutes of Health, Department of Health and Human Services, under Federal Award Number U54HL143541.<\/p>\n<p>\n        <em>The Revogene<\/em><br \/>\n        <sup>\u00ae<\/sup><br \/>\n        <em> SARS-CoV-2 Molecular Diagnostic Test has not been FDA cleared or approved.<\/em>\n      <\/p>\n<p align=\"justify\">For more information on the Revogene\u00ae SARS-CoV-2 test, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YQ-nOp9DuuS88mV5gnX_sHcHfd3A_bFYjq0SFT2FMcepeOzg7l9Rr6IHFLHo5cLrn0n4p4TYVpLnqkJw70vwN40e35aYfltfy3mBP3RnGB2scYk1shwfWsugQ4n5ZX-wVTRlEGHNYHrBbAy4XYNNnVssc1N56bD45udnO_70VgD-OO5Hj1g1KA2KmEAlcG5PwsGQvZuJZjYaEPrzmLcVnLu84NnJdBkrd8yzd_MxUiz8PmhU2tEwZ6kxCy-oBnHGrmGd7e2UaAzkshXSiIpSDbkBvakJO7Xx0WTa76ZpcRw=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/www.meridianbioscience.com\/human-condition\/respiratory\/coronavirus\/revogene-sars-cov-2\/<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>About Meridian Bioscience, Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">Meridian is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic products. We are dedicated to developing and delivering better solutions that give answers with speed, accuracy and simplicity that are redefining the possibilities of life from discovery to diagnosis. Through discovery and development, we provide critical life science raw materials used in immunological and molecular tests for human, animal, plant, and environmental applications. Through diagnosis, we provide diagnostic solutions in areas including gastrointestinal and upper respiratory infections and blood lead level testing. We build relationships and provide solutions to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies in more than 70 countries around the world.<\/p>\n<p align=\"justify\">Meridian\u2019s shares are traded on the NASDAQ Global Select Market, symbol VIVO. Meridian\u2019s website address is <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dIbl3BpZDYaY6jJXrNhyzWgIR6NlsFGHXqSLR18I8xeOouPIDE4PT3AAW7Zw1NmpRgZ8qDWSYuT1YyEkIhZFFtnasq6KB2t1aAeLwMP9Uq5NVcV00FJi7nQdnIOm5sMo\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.meridianbioscience.com<\/a>.<\/p>\n<p>\n        <strong>Contact:<\/strong><br \/>\n        <br \/>Charlie Wood<br \/>Vice President \u2013 Investor Relations<br \/>Meridian Bioscience, Inc.<br \/>Phone: +1 513.271.3700<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YOANur0E6PiqIs50SaBkWqyJ9LwBOWpiiKncEzPIzVtvD2fYuU8BA1uv7L9TsTyJDEtc3oIF7DiPNF-2c_2xZQykySAG_51IctLLLapc0kkbZMTDVhrd_E78NQFerMlx_YlgwC-PyN0T8M9JXuILRg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">mbi@meridianbioscience.com<\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMzUyNyMzODg1MTA0IzIwMDYwNjY=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/bc3ee60b-4bf0-4bd7-ba9b-f5399220a239\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CINCINNATI, Dec. 16, 2020 (GLOBE NEWSWIRE) &#8212; Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced that it has been awarded funding in the amount of approximately $1M by the National Institute of Health (NIH) Rapid Acceleration of Diagnostics (RADxSM) initiative, to expedite the launch of the company\u2019s SARS-CoV-2 molecular diagnostic test on the Revogene\u00ae platform. On December 7, the application for Emergency Use Authorization (EUA) for the Revogene\u00ae SARS-CoV-2 assay was submitted to the U.S. Food and Drug Administration (FDA). NIH funds were critical to support the development of a new assay consumable for the Revogene\u00ae platform enabling the detection of RNA targets, such as SARS-CoV-2 genomic RNA, directly from &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/meridian-bioscience-receives-nih-award-for-supporting-rapid-development-of-revogene-molecular-test-for-sars-cov-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Meridian Bioscience receives NIH Award for supporting rapid development of Revogene\u00ae molecular test for SARS-CoV-2&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-401249","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Meridian Bioscience receives NIH Award for supporting rapid development of Revogene\u00ae molecular test for SARS-CoV-2 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/meridian-bioscience-receives-nih-award-for-supporting-rapid-development-of-revogene-molecular-test-for-sars-cov-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Meridian Bioscience receives NIH Award for supporting rapid development of Revogene\u00ae molecular test for SARS-CoV-2 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CINCINNATI, Dec. 16, 2020 (GLOBE NEWSWIRE) &#8212; Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced that it has been awarded funding in the amount of approximately $1M by the National Institute of Health (NIH) Rapid Acceleration of Diagnostics (RADxSM) initiative, to expedite the launch of the company\u2019s SARS-CoV-2 molecular diagnostic test on the Revogene\u00ae platform. On December 7, the application for Emergency Use Authorization (EUA) for the Revogene\u00ae SARS-CoV-2 assay was submitted to the U.S. Food and Drug Administration (FDA). NIH funds were critical to support the development of a new assay consumable for the Revogene\u00ae platform enabling the detection of RNA targets, such as SARS-CoV-2 genomic RNA, directly from &hellip; Continue reading &quot;Meridian Bioscience receives NIH Award for supporting rapid development of Revogene\u00ae molecular test for SARS-CoV-2&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/meridian-bioscience-receives-nih-award-for-supporting-rapid-development-of-revogene-molecular-test-for-sars-cov-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-16T20:03:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMzUyNyMzODg1MTA0IzIwMDYwNjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/meridian-bioscience-receives-nih-award-for-supporting-rapid-development-of-revogene-molecular-test-for-sars-cov-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/meridian-bioscience-receives-nih-award-for-supporting-rapid-development-of-revogene-molecular-test-for-sars-cov-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Meridian Bioscience receives NIH Award for supporting rapid development of Revogene\u00ae molecular test for SARS-CoV-2\",\"datePublished\":\"2020-12-16T20:03:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/meridian-bioscience-receives-nih-award-for-supporting-rapid-development-of-revogene-molecular-test-for-sars-cov-2\\\/\"},\"wordCount\":571,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/meridian-bioscience-receives-nih-award-for-supporting-rapid-development-of-revogene-molecular-test-for-sars-cov-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExMzUyNyMzODg1MTA0IzIwMDYwNjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/meridian-bioscience-receives-nih-award-for-supporting-rapid-development-of-revogene-molecular-test-for-sars-cov-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/meridian-bioscience-receives-nih-award-for-supporting-rapid-development-of-revogene-molecular-test-for-sars-cov-2\\\/\",\"name\":\"Meridian Bioscience receives NIH Award for supporting rapid development of Revogene\u00ae molecular test for SARS-CoV-2 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/meridian-bioscience-receives-nih-award-for-supporting-rapid-development-of-revogene-molecular-test-for-sars-cov-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/meridian-bioscience-receives-nih-award-for-supporting-rapid-development-of-revogene-molecular-test-for-sars-cov-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExMzUyNyMzODg1MTA0IzIwMDYwNjY=\",\"datePublished\":\"2020-12-16T20:03:06+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/meridian-bioscience-receives-nih-award-for-supporting-rapid-development-of-revogene-molecular-test-for-sars-cov-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/meridian-bioscience-receives-nih-award-for-supporting-rapid-development-of-revogene-molecular-test-for-sars-cov-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/meridian-bioscience-receives-nih-award-for-supporting-rapid-development-of-revogene-molecular-test-for-sars-cov-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExMzUyNyMzODg1MTA0IzIwMDYwNjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExMzUyNyMzODg1MTA0IzIwMDYwNjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/meridian-bioscience-receives-nih-award-for-supporting-rapid-development-of-revogene-molecular-test-for-sars-cov-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Meridian Bioscience receives NIH Award for supporting rapid development of Revogene\u00ae molecular test for SARS-CoV-2\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Meridian Bioscience receives NIH Award for supporting rapid development of Revogene\u00ae molecular test for SARS-CoV-2 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/meridian-bioscience-receives-nih-award-for-supporting-rapid-development-of-revogene-molecular-test-for-sars-cov-2\/","og_locale":"en_US","og_type":"article","og_title":"Meridian Bioscience receives NIH Award for supporting rapid development of Revogene\u00ae molecular test for SARS-CoV-2 - Market Newsdesk","og_description":"CINCINNATI, Dec. 16, 2020 (GLOBE NEWSWIRE) &#8212; Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced that it has been awarded funding in the amount of approximately $1M by the National Institute of Health (NIH) Rapid Acceleration of Diagnostics (RADxSM) initiative, to expedite the launch of the company\u2019s SARS-CoV-2 molecular diagnostic test on the Revogene\u00ae platform. On December 7, the application for Emergency Use Authorization (EUA) for the Revogene\u00ae SARS-CoV-2 assay was submitted to the U.S. Food and Drug Administration (FDA). NIH funds were critical to support the development of a new assay consumable for the Revogene\u00ae platform enabling the detection of RNA targets, such as SARS-CoV-2 genomic RNA, directly from &hellip; Continue reading \"Meridian Bioscience receives NIH Award for supporting rapid development of Revogene\u00ae molecular test for SARS-CoV-2\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/meridian-bioscience-receives-nih-award-for-supporting-rapid-development-of-revogene-molecular-test-for-sars-cov-2\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-16T20:03:06+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMzUyNyMzODg1MTA0IzIwMDYwNjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/meridian-bioscience-receives-nih-award-for-supporting-rapid-development-of-revogene-molecular-test-for-sars-cov-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/meridian-bioscience-receives-nih-award-for-supporting-rapid-development-of-revogene-molecular-test-for-sars-cov-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Meridian Bioscience receives NIH Award for supporting rapid development of Revogene\u00ae molecular test for SARS-CoV-2","datePublished":"2020-12-16T20:03:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/meridian-bioscience-receives-nih-award-for-supporting-rapid-development-of-revogene-molecular-test-for-sars-cov-2\/"},"wordCount":571,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/meridian-bioscience-receives-nih-award-for-supporting-rapid-development-of-revogene-molecular-test-for-sars-cov-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMzUyNyMzODg1MTA0IzIwMDYwNjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/meridian-bioscience-receives-nih-award-for-supporting-rapid-development-of-revogene-molecular-test-for-sars-cov-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/meridian-bioscience-receives-nih-award-for-supporting-rapid-development-of-revogene-molecular-test-for-sars-cov-2\/","name":"Meridian Bioscience receives NIH Award for supporting rapid development of Revogene\u00ae molecular test for SARS-CoV-2 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/meridian-bioscience-receives-nih-award-for-supporting-rapid-development-of-revogene-molecular-test-for-sars-cov-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/meridian-bioscience-receives-nih-award-for-supporting-rapid-development-of-revogene-molecular-test-for-sars-cov-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMzUyNyMzODg1MTA0IzIwMDYwNjY=","datePublished":"2020-12-16T20:03:06+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/meridian-bioscience-receives-nih-award-for-supporting-rapid-development-of-revogene-molecular-test-for-sars-cov-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/meridian-bioscience-receives-nih-award-for-supporting-rapid-development-of-revogene-molecular-test-for-sars-cov-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/meridian-bioscience-receives-nih-award-for-supporting-rapid-development-of-revogene-molecular-test-for-sars-cov-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMzUyNyMzODg1MTA0IzIwMDYwNjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMzUyNyMzODg1MTA0IzIwMDYwNjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/meridian-bioscience-receives-nih-award-for-supporting-rapid-development-of-revogene-molecular-test-for-sars-cov-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Meridian Bioscience receives NIH Award for supporting rapid development of Revogene\u00ae molecular test for SARS-CoV-2"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/401249","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=401249"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/401249\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=401249"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=401249"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=401249"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}